|
ZNF667 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.02671254515508E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.177200E-04 |
| Normal-vs-Stage2 |
1.59757999999011E-05 |
| Normal-vs-Stage3 |
5.36489741520541E-11 |
| Normal-vs-Stage4 |
2.47789566643064E-11 |
| Stage1-vs-Stage2 |
4.449700E-02 |
| Stage1-vs-Stage3 |
9.812400E-04 |
| Stage1-vs-Stage4 |
2.556500E-04 |
| Stage2-vs-Stage3 |
8.131200E-01 |
| Stage2-vs-Stage4 |
5.490400E-01 |
| Stage3-vs-Stage4 |
6.669800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.78046466459136E-12 |
| Normal-vs-AfricanAmerican |
6.112000E-01 |
| Normal-vs-Asian |
2.725600E-01 |
| Caucasian-vs-AfricanAmerican |
2.529900E-02 |
| Caucasian-vs-Asian |
7.561800E-01 |
| AfricanAmerican-vs-Asian |
5.200400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.02222699591448E-12 |
| Normal-vs-Female |
1.7503799999985E-05 |
| Male-vs-Female |
1.199360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.742700E-03 |
| Normal-vs-Age(41-60Yrs) |
1.62650004575937E-09 |
| Normal-vs-Age(61-80Yrs) |
1.96799999963027E-07 |
| Normal-vs-Age(81-100Yrs) |
7.820300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.258200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.916200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.653000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.006800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.094400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.890400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.526000E-01 |
| Normal-vs-Grade 2 |
1.040050E-02 |
| Normal-vs-Grade 3 |
3.99680288865056E-15 |
| Normal-vs-Grade 4 |
1.04360964314765E-14 |
| Grade 1-vs-Grade 2 |
6.638600E-01 |
| Grade 1-vs-Grade 3 |
5.415600E-01 |
| Grade 1-vs-Grade 4 |
2.954000E-01 |
| Grade 2-vs-Grade 3 |
5.63129999999745E-05 |
| Grade 2-vs-Grade 4 |
2.28300000015835E-07 |
| Grade 3-vs-Grade 4 |
7.469800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.09050000141053E-08 |
| Normal-vs-ccB subtype |
2.83420000002366E-06 |
| ccA subtype-vs-ccB subtype |
8.926400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.71669999829527E-08 |
| Normal-vs-N1 |
8.7539975268669E-12 |
| N0-vs-N1 |
8.172900E-04 |
|
|
